BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35525391)

  • 1. Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases.
    Snyder BL; Blackshear PJ
    Pharmacol Ther; 2022 Nov; 239():108198. PubMed ID: 35525391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tristetraprolin as a Therapeutic Target in Inflammatory Disease.
    Patial S; Blackshear PJ
    Trends Pharmacol Sci; 2016 Oct; 37(10):811-821. PubMed ID: 27503556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
    Patial S; Curtis AD; Lai WS; Stumpo DJ; Hill GD; Flake GP; Mannie MD; Blackshear PJ
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1865-70. PubMed ID: 26831084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.
    Makita S; Takatori H; Nakajima H
    Front Immunol; 2021; 12():711633. PubMed ID: 34276705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
    Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
    RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.
    Qiu LQ; Lai WS; Bradbury A; Zeldin DC; Blackshear PJ
    J Leukoc Biol; 2015 Apr; 97(4):723-36. PubMed ID: 25657290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis.
    Xu B; Tang J; Lyu C; Wandu WS; Stumpo DJ; Mattapallil MJ; Horai R; Gery I; Blackshear PJ; Caspi RR
    Front Immunol; 2020; 11():583510. PubMed ID: 33569048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Knock-In Tristetraprolin (TTP) Zinc Finger Point Mutation in Mice: Comparison with Complete TTP Deficiency.
    Lai WS; Stumpo DJ; Qiu L; Faccio R; Blackshear PJ
    Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29203639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner.
    Kratochvill F; Gratz N; Qualls JE; Van De Velde LA; Chi H; Kovarik P; Murray PJ
    Cancer Res; 2015 Aug; 75(15):3054-64. PubMed ID: 26183929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tristetraprolin overexpression drives hematopoietic changes in young and middle-aged mice generating dominant mitigating effects on induced inflammation in murine models.
    Tanaka-Yano M; Zong L; Park B; Yanai H; Tekin-Turhan F; Blackshear PJ; Beerman I
    Geroscience; 2024 Feb; 46(1):1271-1284. PubMed ID: 37535204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic roles of tristetraprolin family members in myeloid cells in the control of inflammation.
    Snyder BL; Huang R; Burkholder AB; Donahue DR; Mahler BW; Bortner CD; Lai WS; Blackshear PJ
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37903626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.
    Ross EA; Naylor AJ; O'Neil JD; Crowley T; Ridley ML; Crowe J; Smallie T; Tang TJ; Turner JD; Norling LV; Dominguez S; Perlman H; Verrills NM; Kollias G; Vitek MP; Filer A; Buckley CD; Dean JL; Clark AR
    Ann Rheum Dis; 2017 Mar; 76(3):612-619. PubMed ID: 27597652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.
    Lai WS; Parker JS; Grissom SF; Stumpo DJ; Blackshear PJ
    Mol Cell Biol; 2006 Dec; 26(24):9196-208. PubMed ID: 17030620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tristetraprolin in cancer and inflammation.
    Sanduja S; Blanco FF; Young LE; Kaza V; Dixon DA
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):174-88. PubMed ID: 22201737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct binding of specific AUF1 isoforms to tandem zinc finger domains of tristetraprolin (TTP) family proteins.
    Kedar VP; Zucconi BE; Wilson GM; Blackshear PJ
    J Biol Chem; 2012 Feb; 287(8):5459-71. PubMed ID: 22203679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Tristetraprolin Expression or Functional Activity Regulates Inflammatory Response Induced by MSU Crystals.
    Lv L; Qin T; Huang Q; Jiang H; Chen F; Long F; Ren L; Liu J; Xie Y; Zeng M
    Front Immunol; 2021; 12():675534. PubMed ID: 34335573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation.
    Kang JG; Amar MJ; Remaley AT; Kwon J; Blackshear PJ; Wang PY; Hwang PM
    J Immunol; 2011 Sep; 187(5):2696-701. PubMed ID: 21784977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tristetraprolin Regulates T
    Peng H; Ning H; Wang Q; Lai J; Wei L; Stumpo DJ; Blackshear PJ; Fu M; Hou R; Hoft DF; Liu J
    Front Immunol; 2020; 11():1952. PubMed ID: 32922402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.
    Carrick DM; Lai WS; Blackshear PJ
    Arthritis Res Ther; 2004; 6(6):248-64. PubMed ID: 15535838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tristetraprolin deadenylation by poly(A) binding protein.
    Rowlett RM; Chrestensen CA; Schroeder MJ; Harp MG; Pelo JW; Shabanowitz J; DeRose R; Hunt DF; Sturgill TW; Worthington MT
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G421-30. PubMed ID: 18467502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.